1. Home
  2. TRVG vs RNAC Comparison

TRVG vs RNAC Comparison

Compare TRVG & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.91

Market Cap

278.1M

Sector

Technology

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$8.42

Market Cap

204.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
RNAC
Founded
2005
2007
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
278.1M
204.6M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
TRVG
RNAC
Price
$2.91
$8.42
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$3.96
$38.40
AVG Volume (30 Days)
50.6K
192.2K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$614,486,683.00
$1,091,000.00
Revenue This Year
$18.36
N/A
Revenue Next Year
$9.18
N/A
P/E Ratio
$99.14
N/A
Revenue Growth
14.41
N/A
52 Week Low
$2.02
$5.98
52 Week High
$5.83
$23.93

Technical Indicators

Market Signals
Indicator
TRVG
RNAC
Relative Strength Index (RSI) 41.52 61.06
Support Level $2.86 $6.66
Resistance Level $3.00 $8.40
Average True Range (ATR) 0.12 0.54
MACD -0.01 0.22
Stochastic Oscillator 29.63 87.10

Price Performance

Historical Comparison
TRVG
RNAC

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: